Coherus Biosciences Stock Price on December 3, 2024
| CHRS Stock | USD 1.52 0.04 2.70% |
Below is the normalized historical share price chart for Coherus BioSciences extending back to November 06, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Coherus BioSciences stands at 1.52, as last reported on the 24th of December, with the highest price reaching 1.54 and the lowest price hitting 1.40 during the day.
If you're considering investing in Coherus Stock, it is important to understand the factors that can impact its price. Coherus BioSciences appears to be very risky, given 3 months investment horizon. Coherus BioSciences secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. By analyzing Coherus BioSciences' technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please makes use of Coherus BioSciences' Risk Adjusted Performance of 0.0836, mean deviation of 4.99, and Downside Deviation of 5.02 to double-check if our risk estimates are consistent with your expectations.
Common Stock Shares Outstanding is likely to drop to about 54.8 M in 2024. Total Stockholder Equity is likely to gain to about (183.8 M) in 2024. Price Earnings To Growth Ratio is likely to gain to 0.03 in 2024, whereas Price To Sales Ratio is likely to drop 1.16 in 2024. Coherus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of November 2014 | 200 Day MA 1.5628 | 50 Day MA 1.0967 | Beta 0.693 |
Coherus |
Sharpe Ratio = 0.1252
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CHRS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.44 actual daily | 66 66% of assets are less volatile |
Expected Return
| 0.93 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Coherus BioSciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Coherus BioSciences by adding it to a well-diversified portfolio.
Price Book 73.1897 | Enterprise Value Ebitda 9.2681 | Price Sales 0.5754 | Shares Float 103.3 M | Wall Street Target Price 5.9 |
Coherus BioSciences Main Headline on 3rd of December 2024
Coherus Announces Agreement to Divest UDENYCA Franchise for ... by gurufocus.com
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI, an FDA approved, next-generation programmed cell death protein 1
Coherus BioSciences Valuation on December 3, 2024
It is possible to determine the worth of Coherus BioSciences on a given historical date. On December 3, 2024 Coherus was worth 2.04 at the beginning of the trading date compared to the closed value of 1.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Coherus BioSciences stock. Still, in general, we apply an absolute valuation method to find Coherus BioSciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Coherus BioSciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Coherus BioSciences' related companies.
| Open | High | Low | Close | Volume | |
| 1.25 | 1.38 | 1.22 | 1.37 | 4,337,392 | |
12/03/2024 | 2.04 | 2.43 | 1.67 | 1.71 | 114,890,676 |
| 1.82 | 1.95 | 1.68 | 1.71 | 13,164,770 |
| Backtest Coherus BioSciences | | | Coherus BioSciences History | | | Coherus BioSciences Valuation | Previous | Next |
Coherus BioSciences Trading Date Momentum on December 3, 2024
| On December 04 2024 Coherus BioSciences was traded for 1.71 at the closing time. The top price for the day was 1.95 and the lowest listed price was 1.68 . The trading volume for the day was 13.2 M. The trading history from December 4, 2024 did not affect price variability. The overall trading delta against the current closing price is 12.28% . |
Coherus BioSciences Fundamentals Correlations and Trends
By evaluating Coherus BioSciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Coherus BioSciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Coherus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Coherus BioSciences Stock history
Coherus BioSciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Coherus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Coherus BioSciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Coherus BioSciences stock prices may prove useful in developing a viable investing in Coherus BioSciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 94.2 M | 54.8 M | |
| Net Loss | -262.6 M | -249.4 M |
Coherus BioSciences Quarterly Net Working Capital |
|
Coherus BioSciences Stock Technical Analysis
Coherus BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Coherus BioSciences Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Coherus BioSciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Coherus BioSciences December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Coherus BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Coherus BioSciences shares will generate the highest return on investment. By undertsting and applying Coherus BioSciences stock market strength indicators, traders can identify Coherus BioSciences entry and exit signals to maximize returns
Coherus BioSciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Coherus BioSciences' price direction in advance. Along with the technical and fundamental analysis of Coherus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Coherus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0836 | |||
| Jensen Alpha | 0.6399 | |||
| Total Risk Alpha | 0.4711 | |||
| Sortino Ratio | 0.1324 | |||
| Treynor Ratio | 0.3339 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.